Search

everythinglearnresearchcommunity

for

Search:↓

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Some teenagers with anorexia nervosa have worse cognitive abilities, especially in visual and spatial tasks, and this is more common in those with a lower body weight.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Greater intimacy leads to better self-reported health in couples having infertility treatment.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Non-obese women with hair loss have higher heart disease risk.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Hair loss linked to higher heart disease risk in both men and women.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.